GlassScriptPhysician profile
Bimalkumar Brahmbhatt
NPI 1215986500
$31,052.19
in general payments reported to CMS, 2019-2025
48 companies · $2,248 in 2025
The $2,248 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,803 · 2021: $2,204 · 2022: $4,981 · 2023: $3,553 · 2024: $2,942 · 2025: $2,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,236 · Travel and Lodging: $311 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,236.02 |
| Travel and Lodging | $311.25 |
| Education | $194.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,842.95 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $2,063.81 | 2019-2025 | Watchman Access System, Watchman Flx |
| Medtronic, INC. | $2,033.37 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan, Micra |
| Medtronic Vascular, INC. | $1,978.04 | 2019-2020 | |
| Novo Nordisk INC | $1,556.86 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $1,473.87 | 2019-2025 | Amplatzer Amulet, Mitraclip, Cardiomems |
| Janssen Pharmaceuticals, INC | $1,379.34 | 2019-2024 | Xarelto |
| Amgen INC. | $1,082.80 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $998.10 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $866.19 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $780.71 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $756.77 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $586.71 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $584.06 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $542.42 | 2019-2025 | Uptravi, Opsumit |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $495.79 | 2019-2025 | Farxiga, Lokelma, Brilinta |
| Biotronik INC. | $455.09 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $327.39 | 2019-2025 | Evkeeza |
| Esperion Therapeutics, INC. | $327.20 | 2020-2025 | Nexletol |
| Abbvie INC. | $293.80 | 2023-2025 | Teflaro, Avycaz |
| Elutia, INC. | $283.80 | 2019-2020 | |
| Edwards Lifesciences Corporation | $230.34 | 2019-2023 | Sapien 3 Ultra Resilia |
| Scpharmaceuticals INC. | $226.26 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $220.22 | 2022-2025 | Assure Wcd |
| Chiesi USA, INC. | $207.16 | 2020-2025 | Cleviprex, Kengreal, Juxtapid |
| Arbor Pharmaceuticals, INC. | $187.65 | 2019-2021 | |
| Lilly USA, LLC | $158.35 | 2019-2025 | Zepbound, Mounjaro |
| Lundbeck LLC | $142.65 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $133.93 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $114.71 | 2024 | Arcalyst |
| Heartflow, INC. | $94.36 | 2022-2024 | |
| Cvrx, INC. | $81.46 | 2024-2025 | Barostim Neo System |
| Abiomed | $65.76 | 2025 | |
| Siemens Medical Solutions USA, INC. | $62.39 | 2023 | Acuson Redwood Diagnostic Ultrasound System |
| Kowa Pharmaceuticals America, INC. | $59.04 | 2021-2023 | Livalo |
| Kiniksa Pharmaceuticals, LTD. | $55.44 | 2023 | Arcalyst |
| Bardy Diagnostics, INC. | $54.74 | 2020 | |
| Daiichi Sankyo INC. | $51.38 | 2022-2023 | Injectafer |
| Baxter Healthcare | $26.73 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $26.43 | 2023 | Amvuttra |
| Bridgebio Pharma, INC. | $23.44 | 2025 | Attruby |
| Ionis Pharmaceuticals, INC. | $22.91 | 2025 | Tryngolza |
| Inspire Medical Systems, INC. | $22.80 | 2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $18.18 | 2025 | Gattex |
| Medicomp INC | $16.61 | 2025 | Telepatch Cardiac Monitor |
| Allergan, INC. | $14.20 | 2019 | |
| Gilead Sciences, INC. | $13.52 | 2019 | |
| Vifor Pharma, INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bimalkumar Brahmbhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.